compounding glp-1 enforcement news Compounding: When Innovation May Mean Liability FDA Moves to Restrict Mass-Marketed

Anthony Izzo, DO, FAAN, FAASM, sleep center medical director at Community Neuroscience Services, is among a growing number of sleep medicine specialists who prescribe GLP-1s

The most common side effect was nausea and one patient out of 16 withdrew due to diarrhea

S., Emadi, A., & Shab-Bidar, S

Methods We obtained the data from PubMed, Scopus, Embase, and Web of Science for all eligible studies, including clinical trials (RCT) and cohorts comparing GLP-1 RAs to placebo or other hypoglycemic agents in patients with HFpEF published until December 31st, 2024

Its an outright admission that Novo was manipulating future demand, he told the panel